Abbvie Inc. (NYSE:ABBV) reported Q4 adjusted earnings Thursday of $3.60 per diluted share,Analysts polled by Capital IQ expected $3.58.
Revenue for the quarter ended Dec. 31 was $15.12 billion, Analysts surveyed by Capital IQ expected $15.30 billion.
For the full year of 2023, the company is expecting adjusted earnings of $10.70 to $11.10 per diluted share. Analysts polled by Capital IQ are expecting $11.68.